HIRSCHMAN ORIN 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-30 4:05 pm Purchase |
2023-06-06 | 13G | Soleno Therapeutics, Inc. SLNO |
HIRSCHMAN ORIN | 498,610 4.900% |
76,121 (+18.02%) |
Filing |
| 2023-02-15 07:26 am Sale |
2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
HIRSCHMAN ORIN | 422,489 5.200% |
-30,844 (-6.80%) |
Filing |
| 2022-04-05 08:05 am Purchase |
2022-03-29 | 13G | Soleno Therapeutics, Inc. SLNO |
HIRSCHMAN ORIN | 453,333 5.700% |
453,333 (New Position) |
Filing |